TL1A Aggravates Cytokine-Induced Acute Gut Inflammation and Potentiates Infiltration of Intraepithelial Natural Killer Cells in Mice
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
TL1A Aggravates Cytokine-Induced Acute Gut Inflammation and Potentiates Infiltration of Intraepithelial Natural Killer Cells in Mice. / Tougaard, Peter; Martinsen, Louise Otterstrøm; Zachariassen, Line Fisker; Krych, Lukasz; Nielsen, Dennis Sandris; Buus, Terkild Brink; Pedersen, Anders Elm; Hansen, Axel Kornerup; Skov, Søren; Hansen, Camilla Hartmann Friis.
In: Inflammatory Bowel Diseases, Vol. 25, No. 3, 2019, p. 510-523.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - TL1A Aggravates Cytokine-Induced Acute Gut Inflammation and Potentiates Infiltration of Intraepithelial Natural Killer Cells in Mice
AU - Tougaard, Peter
AU - Martinsen, Louise Otterstrøm
AU - Zachariassen, Line Fisker
AU - Krych, Lukasz
AU - Nielsen, Dennis Sandris
AU - Buus, Terkild Brink
AU - Pedersen, Anders Elm
AU - Hansen, Axel Kornerup
AU - Skov, Søren
AU - Hansen, Camilla Hartmann Friis
PY - 2019
Y1 - 2019
N2 - BackgroundThe tumor necrosis factor alpha (TNFα)–homologous cytokine TL1A is emerging as a major player in intestinal inflammation. From in vitro experiments on human lymphocytes, TNF-like molecule 1A (TL1A) is known to activate a highly inflammatory lymphoid response in synergy with interleukin (IL)-12 and IL-18. Carriers of specific genetic polymorphisms associated with IL-12, IL-18, or TL1A signaling have increased Crohn’s disease risk, and all 3 cytokines are upregulated during active disease. The study aim was to investigate whether the type 1–polarizing cytokines IL-12 and IL-18 could directly initiate intestinal pathology in mice and how TL1A would influence the resulting inflammatory response.MethodsConventional barrier-bred and germ-free mice were randomly allocated to different groups and injected twice with different combinations of IL-12, IL-18, and TL1A, and killed 3 days after the first injection. All treatment groups were co-housed and fed a piroxicam-supplemented chow diet.ResultsIntestinal pathology was evident in IL-12- and IL-18-treated mice and highly exacerbated by TL1A in both the colon and ileum. The cytokine-induced intestinal inflammation was characterized by epithelial damage, increased colonic levels of TNFα, IL-1β, IFN-γ, and IL-6, and various chemokines along with gut microbiota alterations exhibiting high abundance of Enterobacteriaceae. Furthermore, the inflamed ileum and colon exhibited a TL1A-specific increased infiltration of intraepithelial natural killer cells co-expressing NKG2D and IL-18Ra and a higher frequency of unconventional T cells in the colonic epithelium. Upon cytokine injection, germ-free mice exhibited similar intraepithelial lymphoid infiltration and increased colonic levels of IFNγ and TNFα.ConclusionsThis study demonstrates that TL1A aggravates IL-12- and IL-18-induced intestinal inflammation in the presence and absence of microbiota.
AB - BackgroundThe tumor necrosis factor alpha (TNFα)–homologous cytokine TL1A is emerging as a major player in intestinal inflammation. From in vitro experiments on human lymphocytes, TNF-like molecule 1A (TL1A) is known to activate a highly inflammatory lymphoid response in synergy with interleukin (IL)-12 and IL-18. Carriers of specific genetic polymorphisms associated with IL-12, IL-18, or TL1A signaling have increased Crohn’s disease risk, and all 3 cytokines are upregulated during active disease. The study aim was to investigate whether the type 1–polarizing cytokines IL-12 and IL-18 could directly initiate intestinal pathology in mice and how TL1A would influence the resulting inflammatory response.MethodsConventional barrier-bred and germ-free mice were randomly allocated to different groups and injected twice with different combinations of IL-12, IL-18, and TL1A, and killed 3 days after the first injection. All treatment groups were co-housed and fed a piroxicam-supplemented chow diet.ResultsIntestinal pathology was evident in IL-12- and IL-18-treated mice and highly exacerbated by TL1A in both the colon and ileum. The cytokine-induced intestinal inflammation was characterized by epithelial damage, increased colonic levels of TNFα, IL-1β, IFN-γ, and IL-6, and various chemokines along with gut microbiota alterations exhibiting high abundance of Enterobacteriaceae. Furthermore, the inflamed ileum and colon exhibited a TL1A-specific increased infiltration of intraepithelial natural killer cells co-expressing NKG2D and IL-18Ra and a higher frequency of unconventional T cells in the colonic epithelium. Upon cytokine injection, germ-free mice exhibited similar intraepithelial lymphoid infiltration and increased colonic levels of IFNγ and TNFα.ConclusionsThis study demonstrates that TL1A aggravates IL-12- and IL-18-induced intestinal inflammation in the presence and absence of microbiota.
KW - intraepithelial lymphocytes
KW - NKG2D
KW - cytokine synergy
U2 - 10.1093/ibd/izy351
DO - 10.1093/ibd/izy351
M3 - Journal article
C2 - 30462201
VL - 25
SP - 510
EP - 523
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
SN - 1078-0998
IS - 3
ER -
ID: 215358470